4.7 Review

Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer's Disease

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 35, Issue 4, Pages 270-292

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2020.8129

Keywords

advanced glycation end-products; ferroptosis; glutaredoxin; thioredoxin; nanoparticles

Funding

  1. Research Chair Louise & Andre' Charron on Alzheimer's disease
  2. Foundation ArmandFrappier
  3. Fonds de Recherche du Que'bec-Nature et Technologies (FRQNT)
  4. NSERC

Ask authors/readers for more resources

Glutathione plays a significant role as an antioxidant in the brain related to Alzheimer's disease, with alterations in its levels correlated with cognitive decline. Strategies have been developed to restore its intracellular level, but no significant benefits have been reported in clinical trials so far. Future directions include utilizing GSH-coupled nanocarriers for brain delivery and investigating its presence in exosomes for potential intercellular transfer.
Significance: Glutathione (GSH) represents the most abundant and the main antioxidant in the body with important functions in the brain related to Alzheimer's disease (AD). Recent Advances: Oxidative stress is one of the central mechanisms in AD. We and others have demonstrated the alteration of GSH levels in the AD brain, its important role in the detoxification of advanced glycation end-products and of acrolein, a by-product of lipid peroxidation. Recent in vivo studies found a decrease of GSH in several areas of the brain from control, mild cognitive impairment, and AD subjects, which are correlated with cognitive decline. Critical Issues: Several strategies were developed to restore its intracellular level with the l-cysteine prodrugs or the oral administration of gamma-glutamylcysteine to prevent alterations observed in AD. To date, no benefit on GSH level or on oxidative biomarkers has been reported in clinical trials. Thus, it remains uncertain if GSH could be considered a potential preventive or therapeutic approach or a biomarker for AD. Future Directions: We address how GSH-coupled nanocarriers represent a promising approach for the functionalization of nanocarriers to overcome the blood/brain barrier (BBB) for the brain delivery of GSH while avoiding cellular toxicity. It is also important to address the presence of GSH in exosomes for its potential intercellular transfer or its shuttle across the BBB under certain conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Inhibition of protein glycation, antioxidant and antiproliferative activities of Carpobrotus edulis extracts

Jawhar Hafsa, Khaoula Mkadmini Hammi, Med Raafet Ben Khedher, Med Ali Smach, Bassem Charfeddine, Khalifa Limem, Hatem Majdoub

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Food Science & Technology

Physical, antioxidant and antimicrobial properties of chitosan films containing Eucalyptus globulus essential oil

Jawhar Hafsa, Med ali Smach, Med Raafet Ben Khedher, Bassem Charfeddine, Khalifa Limem, Hatem Majdoub, Sonia Rouatbi

LWT-FOOD SCIENCE AND TECHNOLOGY (2016)

Article Biochemistry & Molecular Biology

Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction

Mohamed Raafet Ben Khedher, Houda Bouhajja, Samia Haj Ahmed, Mohamed Abid, Kamel Jamoussi, Mohamed Hammami

LIPIDS IN HEALTH AND DISEASE (2017)

Article Multidisciplinary Sciences

Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to rosiglitazone

Mohamed R. Ben Khedher, Mohamed Hammami, Jonathan R. S. Arch, David C. Hislop, Dominic Eze, Edward T. Wargent, Magorzata A. Kepczynska, Mohamed S. Zaibi

PEERJ (2018)

Article Biochemistry & Molecular Biology

Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles

Mohamed Haddad, Morgane Perrotte, Mohamed Raafet Ben Khedher, Clement Demongin, Aurelie Lepage, Tamas Fulop, Charles Ramassamy

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Plant Sciences

Inhibition of Protein Glycation by Combined Antioxidant and Antiglycation Constituents from a Phenolic Fraction of Sage (Salvia officinalisL.)

Mohamed Raafet Ben Khedher, Jawhar Hafsa, Mohamed Haddad, Mohamed Hammami

PLANT FOODS FOR HUMAN NUTRITION (2020)

Article Neurosciences

Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients

Mohamed Haddad, Morgane Perrotte, Mohamed Raafet Ben Khedher, Elise Madec, Aurelie Lepage, Tamas Fulop, Charles Ramassamy

Summary: The study found that levels of RAGE and GLO-1 in circulating EVs were correlated with cognitive function in AD patients, and demonstrated for the first time that GLO-1 can be released by neuronal cells through EVs. These findings support the use of peripheral EVs as a new tool for discovering AD biomarkers.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Clinical Neurology

Apolipoprotein E4-driven effects on inflammatory and neurotrophic factors in peripheral extracellular vesicles from cognitively impaired, no dementia participants who converted to Alzheimer's disease

Mohamed Raafet Ben Khedher, Mohamed Haddad, Danielle Laurin, Charles Ramassamy

Summary: This study found that levels of neurotrophic and inflammatory markers are reduced in pEVs from APOE ε4(+) individuals, and the pentraxin-2/alpha-synuclein ratio in pEVs could serve as an early biomarker for AD susceptibility in APOE ε4(+)-CIND individuals. These findings suggest an alteration in the endosomal pathway in APOE ε4(+) individuals.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Article Clinical Neurology

Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease

Mohamed Raafet Ben Khedher, Mohamed Haddad, Danielle Laurin, Charles Ramassamy

Summary: The study examined the impact of APOE epsilon 4 on antioxidant apolipoproteins in circulating extracellular vesicles and plasma from individuals with cognitive impairment. Results showed that total antioxidant capacity and apolipoprotein D levels in cEVs could differentiate APOE epsilon 4 carriers from controls and predict their progression to AD after 5 years. These findings support the link between APOE epsilon 4 and AD onset, suggesting the potential use of cEVs oxidative signature in early AD diagnosis.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

Article Biology

CHEMICAL COMPOSITION AND BIOLOGICAL ACTIVITIES OF SALVIA OFFICINALIS ESSENTIAL OIL FROM TUNISIA

Med Raafet Ben Khedher, Saoussen Ben Khedher, Ikbal Chaieb, Slim Tounsi, Mohamed Hammami

EXCLI JOURNAL (2017)

No Data Available